Clinical Trials Browser

Phase 1/2 × INDUSTRY × Pancreatic Adenocarcinoma Metastatic × Clear all

NCT03127124 2024-04-02

QUILT-2.022 NANT-008 in Combination w/ 5-fluorouracil, Bevacizumab, Leucovorin & Oxaliplatin in Subjects With Pancreatic Cancer

Phase 1/2 Withdrawn

Gastrointestinal

Pancreatic Adenocarcinoma Metastatic